Summary
Serial determinations of MPO and NAP activities in granulocytes were performed during the preremission phase and the remission phase in patients with AML. Of 18 patients examined during the preremission period, 9 showed an increased number of MPO deficient PMN. Complete remission was attained in 4 of these, in 3 the number of abnormal granulocytes changed to normal 7, 7 and 14 days before and in 1 simultaneously with the attainment of complete remission. In the other patients no changes in granulocyte MPO activity occurred during the preremission period.
All 20 patients examined during complete remission showed a normal MPO activity in granulocytes. Of eight patients, who at diagnosis had shown abnormal granulocyte MPO activity, three developed relapse. In two of these, an increased number of MPO deficient PMN reappeared two and eight months prior to and in one simultaneous with clinical and laboratory suspicion of relapse. A statistically significant relation between low NAP scores and an increased number of MPO deficient PMN was found (P=0.011).
Serial determinations of MPO activities in PMN, although restricted to cases of AML with initially abnormal values, may prove helpful in predicting achievement of complete remission and may furthermore prove to be useful as an indicator of early relapse.
Similar content being viewed by others
Abbreviations
- AML:
-
acute myeloid leukaemia
- CR:
-
complete remission
- MPO:
-
myeloperoxidase
- NAP:
-
neutrophil alkaline phosphatase
- PMN:
-
polymorphonuclear leucocytes
References
Avnstrøm S, Ralfkjær E, Winkel P, Nissen NI (1985) The relative merit of various cytochemical quantities and manual differential count in predicting remission following chemotherapy of patients with de novo acute myeloblastic leukaemia. Am J Clin Pathol 83: 73–76
Bendix-Hansen K, Nielsen HK (1983) Myeloperoxidase-deficient polymorphonuclear leukocytes (I). Incidence in untreated myeloid leukaemia, lymphoid leukaemia and normal humans. Scand J Haematol 30: 415–419
Bendix-Hansen K, Nielsen HK (1983) Myeloperoxidase-deficient polymorphonuclear leucocytes (II). Longitudinal study in acute myeloid leukaemia, untreated, in remission and in relapse. Scand J Haematol 31: 5–8
Bøyum A (1976) Isolation of lymphocytes, granulocytes and macrophages. Scand J Immunol 5 (Suppl 5): 9–15
Bøyum A (1968) Separation of leucocytes from blood and bone marrow. Scand J Clin Lab Invest 21 (Suppl 97): 77–89
Catovsky D, Galton DAG, Robinson J (1972) Myeloperoxidase deficient neutrophils in acute myeloid leukaemia. Scand J Haematol 9: 142–148
Kaplow LS (1975) Substitute for benzidine in myeloperoxidase stains. Am J Clin Pathol 63: 451
Kaplow LS (1955) A histochemical procedure for localizing and evaluating leucocyte alkaline phosphatase activity in smears of blood and bone marrow. Blood 10: 1023–1029
Suda T, Onai T, Maekawa T (1983) Studies on abnormal polymorphonuclear neutrophils in acute myelogenous leukaemia: Clinical significance and changes after chemotherapy. Am J Hematol 15: 45–56
Winkel P, Olesen T, Nissen NI (1982) Automated cytochemistry in the prediction of remission following chemotherapy of patients with de novo acute myeloid leukaemia. Am J Clin Pathol 77: 50–53
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bendix-Hansen, K. Myeloperoxidase-deficient polymorphonuclear leucocytes. Longitudinal study during the preremission — and the remission phase in acute myeloid leukaemia. Blut 52, 237–242 (1986). https://doi.org/10.1007/BF00321083
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00321083